EPISODE · Nov 19, 2009 · 14 MIN
Implications of the ACCORD, ADVANCE and VA Diabetes Trials
from Diabetes Discourse
Host: Steven Edelman, MD Guest: Richard Bergenstal, MD The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.
Embed this episode
NOW PLAYING
Implications of the ACCORD, ADVANCE and VA Diabetes Trials
No transcript for this episode yet
Similar Episodes
No similar episodes found.